Delivery Order SPE2DB22D2206-SPE2DB25FJB02
Award Date 7/24/25
Potential Completion Date 8/14/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $43,134 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a pharmaceutical product used in medical treatments. This non-set-aside competitive award was issued on August 14, 2025, with an ultimate completion date of September 5, 2025. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $93,868.32 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is...
- The Defense Logistics Agency awarded a $11,174.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Xeomin 200 Unit Vials, with completion scheduled for August 8, 2025. This competitively awarded contract, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,984.25 for 100-unit vials of Xeomin on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. Xeomin is a botulinum toxin product used for therapeutic and cosmetic applications, and this delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $13,409.76 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials, with a completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on August 13, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order falls under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,587.40 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 unit vials, with performance to be completed by August 25, 2025. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible contractors....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,117.48 by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of Xeomin 100 Unit Vials. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 28, 2025, and represents a child order under a larger contract vehicle. The award carries no set-aside designation, reflecting open...
- The Defense Logistics Agency awarded a $1,215.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 50-unit vials of Xeomin, a botulinum toxin product used for medical and therapeutic purposes. This non-set-aside contract was competitively awarded with an ultimate completion date of August 28, 2025, and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- This delivery order, awarded July 25, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, covers the supply of Xeomin 100 Unit Vials with a ceiling value of $1,396.85 and an ultimate completion date of August 15, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a $8,381.10 delivery order to AmerisourceBergen Drug Corp for 200 unit vials of XEOMIN, a pharmaceutical product used for neurological treatment applications. This firm fixed-price contract, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...